Obinutuzumab Rescue in Rituximab Resistant Mixed Cryoglobulinemia

被引：3
|
作者：
Genest, Dominique S. [1 ]
Pelletier, Karyne [1 ]
Dallaire, Gabriel [2 ]
Faucher, Genevieve [3 ]
Troyanov, Stephan [1 ]
机构：
[1] Hop Sacre Coeur Montreal, Div Nephrol, 5400 Boul Gouin Ouest, Montreal, PQ H4J 1C5, Canada
[2] Hop Sacre Coeur Montreal, Dept Pharm, Montreal, PQ, Canada
[3] Hotel Dieu St Jerome, Div Hematol, St Jerome, PQ, Canada
来源：
KIDNEY INTERNATIONAL REPORTS | 2021年 / 6卷 / 03期
关键词：
D O I：
10.1016/j.ekir.2021.01.033
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：865 / 866
页数：2
相关论文
共 50 条
  • [1] Should rituximab be the rescue therapy for refractory mixed cryoglobulinemia associated with hepatitis C?
    Ahmed, Muhammad S.
    Wong, Christopher F.
    JOURNAL OF NEPHROLOGY, 2007, 20 (03) : 350 - 356
  • [2] Rituximab as a Therapeutic Tool in Severe Mixed Cryoglobulinemia
    Dario Roccatello
    Simone Baldovino
    Daniela Rossi
    Osvaldo Giachino
    Morteza Mansouri
    Carla Naretto
    Debora Di Simone
    Simona Francica
    Roberto Cavallo
    Mirella Alpa
    Franca Napoli
    Luigi M. Sena
    Clinical Reviews in Allergy & Immunology, 2008, 34 : 111 - 117
  • [3] Rituximab as a therapeutic tool in severe mixed Cryoglobulinemia
    Roccatello, Dario
    Baldovino, Simone
    Rossi, Daniela
    Giachino, Osvaldo
    Mansouri, Morteza
    Naretto, Carla
    Di Simone, Debora
    Francica, Simona
    Cavallo, Roberto
    Alpa, Mirella
    Napoli, Franca
    Sena, Luigi M.
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2008, 34 (01) : 111 - 117
  • [4] Rituximab for the treatment of type II mixed cryoglobulinemia
    Zaja, F
    Russo, D
    Fuga, G
    Patriarca, F
    Ermacora, A
    Baccarani, M
    HAEMATOLOGICA, 1999, 84 (12) : 1157 - 1158
  • [5] Efficacy and safety of rituximab in type II mixed cryoglobulinemia
    Zaja, F
    De Vita, S
    Mazzaro, C
    Sacco, S
    Damiani, D
    De Marchi, G
    Michelutti, A
    Baccarani, M
    Fanin, R
    Ferraccioli, G
    BLOOD, 2003, 101 (10) : 3827 - 3834
  • [6] Efficacy of low-dose rituximab for mixed cryoglobulinemia
    Visentini, Marcella
    Granata, Massimo
    Veneziano, Maria Luisa
    Borghese, Federica
    Carlesimo, Maurizio
    Pimpinelli, Fulvia
    Fiorilli, Massimo
    Casato, Milvia
    CLINICAL IMMUNOLOGY, 2007, 125 (01) : 30 - 33
  • [7] Rituximab for the treatment of type II mixed cryoglobulinemia.
    Zaja, F
    De Vita, S
    Sperotto, A
    Sacco, S
    Mazzaro, C
    Tomadini, V
    Ferraccioli, G
    Baccarani, M
    Fanin, R
    BLOOD, 2003, 102 (11) : 54B - 54B
  • [8] Rituximab: A novel treatment for type II mixed cryoglobulinemia
    De Vita, S
    Zaja, F
    De Marchi, G
    Damiani, D
    Sacco, S
    Mazzaro, C
    Fanin, R
    Ferraccioli, G
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 84 - 84
  • [9] Obinutuzumab is effective for the treatment of rituximab-resistant membranous nephropathy
    Lu, Wanhong
    Li, Huixian
    Jin, Li
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I632 - I632
  • [10] Obinutuzumab is effective for the treatment of rituximab-resistant membranous nephropathy
    Lu, Wanhong
    Li, Huixian
    Jin, L., I
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
12345